Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimus.
Journal of Nuclear Medicine.
Times cited: 26
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.
Journal of Clinical Oncology.
Times cited: 1747
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
New England Journal of Medicine.
Times cited: 3322